Charles Schwab Investment Management Inc Novavax Inc Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Novavax Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,325,508 shares of NVAX stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,325,508

Previous 1,137,960 16.48%

Holding current value

$10.7 Million

Previous $14.4 Million 16.21%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.71 - $17.11 $2.01 Million - $3.21 Million	187,548 Added 16.48%	1,325,508 $16.7 Million
Q2 2024 Aug 12, 2024	BUY	$3.89 - $20.97 $808,108 - $4.36 Million	207,740 Added 22.33%	1,137,960 $14.4 Million
Q1 2024 May 08, 2024	BUY	$3.76 - $6.02 $638,775 - $1.02 Million	169,887 Added 22.34%	930,220 $4.45 Million
Q4 2023 Feb 06, 2024	BUY	$4.8 - $7.67 $273,518 - $437,059	56,983 Added 8.1%	760,333 $3.65 Million
Q3 2023 Nov 08, 2023	BUY	$6.81 - $9.74 $349,175 - $499,408	51,274 Added 7.86%	703,350 $5.09 Million
Q2 2023 Aug 09, 2023	BUY	$6.67 - $9.52 $1.31 Million - $1.87 Million	196,492 Added 43.13%	652,076 $4.84 Million
Q1 2023 May 11, 2023	BUY	$5.76 - $12.48 $223,689 - $484,660	38,835 Added 9.32%	455,584 $3.16 Million
Q4 2022 Feb 13, 2023	BUY	$8.86 - $25.04 $89,565 - $253,129	10,109 Added 2.49%	416,749 $4.28 Million
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $42,333 - $177,055	2,326 Added 0.58%	406,640 $7.4 Million
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $693,310 - $1.44 Million	19,110 Added 4.96%	404,314 $20.8 Million
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $165,329 - $338,815	2,371 Added 0.62%	385,204 $28.4 Million
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $1.67 Million - $2.71 Million	12,436 Added 3.36%	382,833 $54.8 Million
Q3 2021 Nov 16, 2021	BUY	$177.8 - $270.58 $5.74 Million - $8.73 Million	32,256 Added 9.54%	370,397 $76.8 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $14.7 Million - $31.4 Million	-121,721 Reduced 26.47%	338,141 $71.8 Million
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $7.34 Million - $20.8 Million	64,977 Added 16.45%	459,862 $83.4 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $1.04 Million - $1.84 Million	13,159 Added 3.45%	394,885 $44 Million
Q3 2020 Nov 13, 2020	SELL	$79.44 - $178.51 $1.31 Million - $2.95 Million	-16,550 Reduced 4.16%	381,726 $41.4 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $1.62 Million - $9.76 Million	116,715 Added 41.45%	398,276 $33.2 Million
Q1 2020 May 15, 2020	BUY	$3.93 - $16.0 $522,112 - $2.13 Million	132,853 Added 89.34%	281,561 $3.82 Million
Q4 2019 Feb 07, 2020	BUY	$3.69 - $5.22 $34,767 - $49,182	9,422 Added 6.76%	148,708 $592,000
Q3 2019 Nov 08, 2019	BUY	$4.02 - $7.84 $83,350 - $162,554	20,734 Added 17.49%	139,286 $700,000
Q2 2019 Aug 09, 2019	BUY	$4.93 - $12.2 $584,461 - $1.45 Million	118,552 New	118,552 $695,000

Others Institutions Holding NVAX

# of Institutions

292

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Novavax Inc Transaction History